Byron Nash Renal Medullary Carcinoma Awareness Act of 2021

Summary

Official

Byron Nash Renal Medullary Carcinoma Awareness Act of 2021 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

How would you vote on this bill?

Yes No

Bill Progress

Committee is reviewing, marking up, or holding hearings on the bill

Introduced(1/4/21)

Committee

Passed House

Passed Senate

President

Law

Sponsor

Mr. Green

House (D) Texas – 9

Cosponsors (8)

Thompson

House (D) Mississippi

Bacon

House (R) Nebraska

Burgess

(R) TX

Barr

House (R) Kentucky

Mullin

Senate (R) Oklahoma

Payne

(D) NJ

Carson

House (D) Indiana

Norton

House (D) District of Columbia

Topics

Health

Government Spending & Operations

Science & Technology

Latest Action

Referred to the Subcommittee on Health.

Feb 2, 2021